Paloma Partners’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Paloma Partners’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,985	Closed	-$305K	–	2701
2020 Q2	$305K	Buy	+2,985	New	+$319K	0.01%	1466
2020 Q1	–	Sell	-1,920	Closed	-$223K	–	2405
2019 Q4	$223K	Buy	+1,920	New	+$222K	﹤0.01%	1924
2016 Q2	–	Sell	-3,796	Closed	-$435K	–	2463
2016 Q1	$435K	Buy	+3,796	New	+$445K	0.01%	1374

Other funds holding CBPO

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MCP

Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capstone Investment Advisors New York $57.4B AUM 26.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Paloma Partners's CBPO Position: Q3 2020 in Review

Paloma Partners sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2020, closing a stake of 2,985 shares — an estimated $305K sold.

Paloma Partners first reported a position in CBPO in Q1 2016 and held it in 3 quarters. The position peaked at $435K in Q1 2016. 87 funds tracked by Wall St. Rank hold CBPO as of Q3 2020.

Paloma Partners reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2020 after selling out during the quarter.
Paloma Partners sold 2,985 China Biologic Products Holdings, Inc. shares in Q3 2020, an estimated $305K.
Paloma Partners first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 3 quarters.
Paloma Partners's China Biologic Products Holdings, Inc. position peaked at $435K in Q1 2016.
87 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2020.

Based on Paloma Partners's 13F filing for Q3 2020, filed 16 Nov 2020.